Related Experiment Video
Updated: Jun 27, 2026
14:59
Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Endoscopic third ventriculostomy for malfunction in previously shunted infants.
Burçak Bilginer1, Kader Karli Oguz, Nejat Akalan
1Department of Neurosurgery, Hacettepe University School of Medicine, Ankara, Turkey. burcak@tr.net
Summary
Endoscopic third ventriculostomy (ETV) effectively treats shunt malfunction in hydrocephalus patients, offering an alternative to shunt revision. This procedure demonstrated an 80% success rate in a retrospective study.
Area of Science:
- Neurosurgery
- Medical Technology
- Hydrocephalus Management
Background:
- Shunt malfunction is a common complication in hydrocephalus management.
- Endoscopic third ventriculostomy (ETV) is increasingly considered as an alternative to shunt revision.
- This study evaluates the efficacy of ETV in patients with shunt malfunction.
Purpose of the Study:
- To assess the effectiveness of endoscopic third ventriculostomy (ETV) as a treatment for ventriculoperitoneal shunt malfunction.
- To determine the success and failure rates of ETV in this patient population.
Main Methods:
- Retrospective review of clinical data from 45 patients who underwent ETV for shunt malfunction.
- Patients were treated at Hacettepe University School of Medicine between January 2002 and August 2007.
- Cerebrospinal fluid flow was assessed postoperatively using cine-PC MR imaging.
Main Results:
- The study included 45 patients (23 male, 22 female) with various causes of hydrocephalus.
- The overall success rate for ETV in treating shunt malfunction was 80% (36 patients).
- Nine patients (20%) experienced ETV failure and required subsequent shunt insertion.
Conclusions:
- Endoscopic third ventriculostomy is a viable and effective treatment option for managing shunt malfunction in hydrocephalus.
- ETV provides a successful alternative to repeat shunt procedures for many patients.
